A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity
Authors
Keywords
-
Journal
GROWTH FACTORS
Volume 32, Issue 6, Pages 223-235
Publisher
Informa UK Limited
Online
2014-11-21
DOI
10.3109/08977194.2014.984808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
- (2014) M. E. Vail et al. CANCER RESEARCH
- EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
- (2013) Bryan W. Day et al. CANCER CELL
- Gene Sets Identified with Oncogene Cooperativity Analysis Regulate In Vivo Growth and Survival of Leukemia Stem Cells
- (2012) John M. Ashton et al. Cell Stem Cell
- Copy Number Variations of EphA3 Are Associated With Multiple Types of Hematologic Malignancies
- (2012) Ming Guan et al. Clinical Lymphoma Myeloma & Leukemia
- Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival
- (2012) Hong-Qing Xi et al. JOURNAL OF GASTROENTEROLOGY
- Concepts and consequences of Eph receptor clustering
- (2012) Peter W. Janes et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- EPHA3 as a novel therapeutic target in the hematological malignancies
- (2012) Niamh Keane et al. Expert Review of Hematology
- Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma
- (2011) H.-Q. Xi et al. JOURNAL OF CLINICAL PATHOLOGY
- Superior In vivo Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer
- (2010) Teemu T. Junttila et al. CANCER RESEARCH
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
- (2010) Birgit Mosch et al. Journal of Oncology
- The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways
- (2009) M. S. Lim et al. BLOOD
- A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
- (2009) Pina M. Cardarelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The N-linked oligosaccharide at Fc RIIIa Asn-45: an inhibitory element for high Fc RIIIa binding affinity to IgG glycoforms lacking core fucosylation
- (2008) M. Shibata-Koyama et al. GLYCOBIOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Segregation of Axial Motor and Sensory Pathways via Heterotypic Trans-Axonal Signaling
- (2008) B. W. Gallarda et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started